TCL Archive Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy” March 8, 2002
TCL Archive SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis. April 30, 2004
TCL Archive “Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions September 14, 2012
TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013